to $3.2B–$3.25B amid strong portfolio expansion
https://seekingalpha.com/news/4516164-royalty-pharma-raises-2025-top-line-guidance-to-3_2b-3_25b-amid-strong-portfolio-expansion
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.